Bellevue Life Sciences Acquisition Corp. Revenue 2021–2023
Bellevue Life Sciences Acquisition Corp. annual/quarterly revenue history and growth rate from 2021 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Bellevue Life Sciences Acquisition Corp. revenue for the quarter ending September 30, 2024 was 0.
- Bellevue Life Sciences Acquisition Corp. revenue for the twelve months ending September 30, 2024 was 0.
- Bellevue Life Sciences Acquisition Corp. annual revenue for 2023 was 0.
- Bellevue Life Sciences Acquisition Corp. annual revenue for 2022 was 0.
- Bellevue Life Sciences Acquisition Corp. annual revenue for 2021 was 0.
Bellevue Life Sciences Acquisition Corp. (BLAC) — Frequently Asked Questions
Bellevue Life Sciences Acquisition Corp. (BLAC) is a publicly traded US company. It has a market capitalization of $3M. Explore BLAC's stock price, financial statements, earnings history, margins and key ratios below.
What is Bellevue Life Sciences Acquisition Corp.'s market cap?
Bellevue Life Sciences Acquisition Corp. (BLAC) has a market capitalization of $3M.
What is the BLAC stock price?
BLAC trades at $0.41 (-4.65% on the day).
Is BLAC profitable?
In fiscal 2023, Bellevue Life Sciences Acquisition Corp. reported net income of $403,780.
What is BLAC's P/E ratio?
Based on diluted EPS, BLAC has a price-to-earnings (P/E) ratio of about 8.2.